Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease-Reference-Cited by-同舟云学术

Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease

Published:2018-07 Issue:7 Volume:24 Page:549-554
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Mizushima Daisuke^ORCID,Nguyen Dung Thi Hoai,Nguyen Dung Thi,Matsumoto Shoko,Tanuma Junko,Gatanaga Hiroyuki,Trung Nguyen Vu,van Kinh Nguyen,Oka Shinichi

Funder

Global Research Network on Infectious Diseases (J-GRID)

Ministry of Education, Culture, Sport, Science & Technology in Japan

Japan Agency for Medical Research and Development (AMED)

MSD K.K., and honorariums

MSD K.K., Janssen Pharmaceutical K.K.

Trii Pharmaceutical Co.

MSD K.K., Abbott Japan, Co.

Torii Pharmaceutical, Co.

Roche Diagnostics K.K.

ViiV Healthcare

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference31 articles.

1. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study;May;Br Med J,2011

2. Kidney disease in patients with HIV infection and AIDS;Winston;Clin Infect Dis,2008

3. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients;Mocroft;AIDS,2010

4. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study;Mocroft;Lancet HIV,2016

5. Association of tenofovir exposure with kidney disease risk in HIV infection;Scherzer;AIDS,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy;PLOS ONE;2024-06-17

2. Association between tenofovir plasma trough concentrations in the early stage of administration and discontinuation of up to five years tenofovir disoproxil fumarate due to renal function-related adverse events in Japanese HIV-1 infected patients;Journal of Pharmaceutical Health Care and Sciences;2024-05-10

3. Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia;Pharmacology Research & Perspectives;2022-12-30

4. Proximal tubular dysfunction related to tenofovir in people living with HIV/AIDS: a pharmacogenetic study;Pharmacogenetics and Genomics;2022-10-13

5. The risk factors associated with COVID-19-Related death among patients with end‐stage renal disease;BMC Nephrology;2021-01-19